The Thinking of Administration on Safe Medication of the Blind in China

Chinese Journal of Pharmacovigilance ›› 2013, Vol. 10 ›› Issue (10): 600-601.

Previous Articles Next Articles

The Thinking of Administration on Safe Medication of the Blind in China

DONG Duo¹ ,HU Jian¹ ,WU Gui -zhi¹ ,WANG Dan¹ ,LIU Na² ,ZHANG Hao³, CHENG Gang¹

1.Center for Drug Reevaluation, CFDA, Beijing 100045, China;
2.Center for ADR Monitoring of Dalian, Liaoning Dalian 116000, China;
3.Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China

Received:2013-07-29 Revised:2016-03-09 Online:2013-10-08 Published:2016-03-09

Abstract

Abstract: By introducing the current situation of administration on safe medication of the blind in China and taking example by experience of western countries, it put forward the model that policy is oriented, manufacture is responsibility main body and multidisciplinary agencies totally corporate. And also advised the related medicine scope, technical tools to ensure safe medication of the blind.

Key words: the blind, safe medication, administration, thinking

CLC Number:

R95

DONG Duo ,HU Jian ,WU Gui -zhi ,WANG Dan ,LIU Na ,ZHANG Hao, CHENG Gang . The Thinking of Administration on Safe Medication of the Blind in China [J]. Chinese Journal of Pharmacovigilance, 2013, 10(10): 600-601.

[1]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.
[2]	YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping. Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884.
[3]	SHEN Ningning, LIU Yufu, RU Yi, SHI Zhuo, YANG Chunqi, NI Zhexin, XIAO Chengrong, MA Zengchun, WANG Yuguang, GAO Yue. Antifatigue effect of ophiopogonin D on exhaustive swimming in mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 749-753.
[4]	WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei. Acute toxicity of proline Danshensu borneol ester in mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757.
[5]	ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin. Preclinical safety evaluation of Jinkui Shenqi pills [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782.
[6]	ZHU Lan, JIN Zhe, LIU Lihong, ZHONG Lumiao, LIUXiaojun. Risks of Kangfuxiaoyan suppository due to routes of administration [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 306-310.
[7]	LI Meiyun, TANG Guangliang, CHEN Zhihong, HE Xin, CHEN Shenjue, LI Xin, LIU Lihua. Analysis of 107 reports of ADR induced by ribavirin [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 770-774.
[8]	WANG Zhonglan, WANG Yu, HAO Lina, HU Lihua, WANG Xiaoling, ZHAO Zhigang. Taking wrong medicines by children and precautions [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 779-781.
[9]	ZHENG Chengcheng, WANG Huiping, XU Baihui, XU Jiaoyan, LI Beibei, ZHANG Xiaohong, ZHANG Wei, SUN Ying, WANG Enli. Toxicity of Jingfang granule extract on embryo-fetal developmental of rats [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 493-497.
[10]	ZHENG Chengcheng, XU Baihui, XU Jiaoyan, WANG Huiping, LI Beibei, ZHANG Xiaohong, SUN Ying, YAO Jingchun, WANG Enli. Toxicity of Jingfang granule extract on perinatal rats [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 498-504.
[11]	XU Baihui, WANG Enli, ZHENG Chengcheng, XU Jiaoyan, LI Beibei, ZHANG Xiaohong, ZHOU Zhongyi, WANG Yonggang, YAO Jingchun. Toxicity of Jingfang granule extractum by 90 days repeated ingastric administration in rats [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 510-514.
[12]	TAI Xinjuan, MA Hongfeng, LI Jun, MA Weixing, YAN Yawei. 400 reports on adverse drug reactions associated with antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 541-544.
[13]	SHA Mingquan, LI Nannan, XIA Wenjing, WEI Qun, WEN Baoshu. Research and reflection on regulatory science developments of U.S. FDA [J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1055-1059.
[14]	CHEN Ying, Wang Lijin, LI Liang, JIA Yanli, WANG Yu, LI Zike, WEI Na, HAN Gang, WU Chunqi, DONG Yansheng. Evaluation of Psychological Dependency Potential of Dexmedetomidine in Rats in a Self-administration Study [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 821-825.
[15]	XIA Dongsheng, TIAN Chunhua, WANG Tao. Changes of Drug Regulatory Concepts in Evidenced by Enactment and Revision of the Drug Administration Law [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 837-844.

The Thinking of Administration on Safe Medication of the Blind in China

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics